Clinical Cancer Research, Vol 2, Issue 7 1155-1161, Copyright © 1996 by American Association for Cancer Research

ARTICLES

Cyclin D1 amplification as a new predictive classification for squamous cell carcinoma of the esophagus, adding gene information

H Shinozaki, S Ozawa, N Ando, H Tsuruta, M Terada, M Ueda and M Kitajima
Department of Surgery, Keio University, School of Medicine, 35 Shinano-machi, Shinjuku-ku, Tokyo 160, Japan.

The cyclin D1, referred to as PRAD-1, has been mapped to the 11q13 region, and its expression has been detected in squamous cell lines and several primary esophageal carcinomas. We assessed cyclin D1 amplification in 122 squamous cell carcinomas of the esophagus. Samples for DNA extraction were obtained from formalin-fixed paraffin-embedded specimens, and 10 microgram of each DNA sample were subjected to slot blot analysis. The presence of more than three gene copies was considered evidence of gene amplification. Amplification of cyclin D1 was detected in 28 (23%) of 122 cases of squamous cell carcinoma of the esophagus. There were no significant differences between the clinicopathological background factors in groups positive and negative for cyclin D1 amplification, but the survival rate of patients exhibiting amplification was significantly lower (P < 0.001). The groups were stratified according to the pN (pathological N category) factor and pT (pathological T category) factor in the TNM classification, and the cumulative survival rates in the amplification groups were always significantly lower. Amplification of cyclin D1 was correlated with distant organ metastasis after curative operations, but there was no significant difference in lymph node recurrence rates of patients with or without amplification. Cyclin D1 amplification had the second highest partial regression coefficient in the multivariate analysis, after the pN factor. Amplification of cyclin D1 was independent of the TNM classification as a prognostic factor, and was a useful marker for predicting outcome and distant organ metastasis in patients with squamous cell carcinoma of the esophagus. It appears that appropriate treatment can be selected by evaluating both TNM factors and cyclin D1 amplification.

This article has been cited by other articles:

				H. Kikuchi, C. Uchida, T. Hattori, T. Isobe, Y. Hiramatsu, K. Kitagawa, T. Oda, H. Konno, and M. Kitagawa ARA54 is involved in transcriptional regulation of the cyclin D1 gene in human cancer cells Carcinogenesis, August 1, 2007; 28(8): 1752 - 1758. [Abstract] [Full Text] [PDF]

				M.-L. Luo, X.-M. Shen, Y. Zhang, F. Wei, X. Xu, Y. Cai, X. Zhang, Y.-T. Sun, Q.-M. Zhan, M. Wu, et al. Amplification and Overexpression of CTTN (EMS1) Contribute to the Metastasis of Esophageal Squamous Cell Carcinoma by Promoting Cell Migration and Anoikis Resistance Cancer Res., December 15, 2006; 66(24): 11690 - 11699. [Abstract] [Full Text] [PDF]

				K. Nishida, S. Mine, T. Utsunomiya, H. Inoue, M. Okamoto, H. Udagawa, T. Hanai, and M. Mori Global Analysis of Altered Gene Expressions during the Process of Esophageal Squamous Cell Carcinogenesis in the Rat: A Study Combined with a Laser Microdissection and a cDNA Microarray Cancer Res., January 15, 2005; 65(2): 401 - 409. [Abstract] [Full Text] [PDF]

				V. B. Wreesmann, W. Shi, H. T. Thaler, A. Poluri, D. H. Kraus, D. Pfister, A. R. Shaha, J. P. Shah, P. H. Rao, and B. Singh Identification of Novel Prognosticators of Outcome in Squamous Cell Carcinoma of the Head and Neck J. Clin. Oncol., October 1, 2004; 22(19): 3965 - 3972. [Abstract] [Full Text] [PDF]

				H. Takeuchi, S. Ozawa, N. Ando, Y. Kitagawa, M. Ueda, and M. Kitajima Cell-Cycle Regulators and the Ki-67 Labeling Index Can Predict the Response to Chemoradiotherapy and the Survival of Patients With Locally Advanced Squamous Cell Carcinoma of the Esophagus Ann. Surg. Oncol., August 1, 2003; 10(7): 792 - 800. [Abstract] [Full Text] [PDF]

				H. Yamamoto, T. Ochiya, F. Takeshita, H. Toriyama-Baba, K. Hirai, H. Sasaki, H. Sasaki, H. Sakamoto, T. Yoshida, I. Saito, et al. Enhanced Skin Carcinogenesis in Cyclin D1-conditional Transgenic Mice: Cyclin D1 Alters Keratinocyte Response to Calcium-induced Terminal Differentiation Cancer Res., March 1, 2002; 62(6): 1641 - 1647. [Abstract] [Full Text] [PDF]

				K. Nakakuki, I. Imoto, A. Pimkhaokham, Y. Fukuda, Y. Shimada, M. Imamura, T. Amagasa, and J. Inazawa Novel targets for the 18p11.3 amplification frequently observed in esophageal squamous cell carcinomas Carcinogenesis, January 1, 2002; 23(1): 19 - 24. [Abstract] [Full Text] [PDF]

				I. Imoto, Z.-Q. Yang, A. Pimkhaokham, H. Tsuda, Y. Shimada, M. Imamura, M. Ohki, and J. Inazawa Identification of cIAP1 As a Candidate Target Gene within an Amplicon at 11q22 in Esophageal Squamous Cell Carcinomas Cancer Res., September 1, 2001; 61(18): 6629 - 6634. [Abstract] [Full Text] [PDF]

				A.-M. Hui, X. Li, Y.-Z. Shi, T. Takayama, G. Torzilli, and M. Makuuchi Cyclin D1 Overexpression Is a Critical Event in Gallbladder Carcinogenesis and Independently Predicts Decreased Survival for Patients with Gallbladder Carcinoma Clin. Cancer Res., November 1, 2000; 6(11): 4272 - 4277. [Abstract] [Full Text] [PDF]

				T. Ueda, H. Sasaki, Y. Kuwahara, M. Nezu, T. Shibuya, H. Sakamoto, H. Ishii, K. Yanagihara, K.-i. Mafune, M. Makuuchi, et al. Deletion of the Carboxyl-Terminal Exons of K-sam/FGFR2 by Short Homology-mediated Recombination, Generating Preferential Expression ofSpecific Messenger RNAs Cancer Res., December 1, 1999; 59(24): 6080 - 6086. [Abstract] [Full Text] [PDF]

				T. Kusume, H. Tsuda, M. Kawabata, T. Inoue, N. Umesaki, T. Suzuki, and K. Yamamoto The p16-Cyclin D1/CDK4-pRb Pathway and Clinical Outcome in Epithelial Ovarian Cancer Clin. Cancer Res., December 1, 1999; 5(12): 4152 - 4157. [Abstract] [Full Text] [PDF]

				C. A. Muro-Cacho, T. Munoz-Antonia, S. Livingston, and D. Klotch Transforming Growth Factor {beta} Receptors and p27kip in Thyroid Carcinoma Arch Otolaryngol Head Neck Surg, January 1, 1999; 125(1): 76 - 81. [Abstract] [Full Text] [PDF]